4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-042311
Chief Executive Officer sold 58,400 shares at an average $40.00 ($2,335,739)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ciechanover Isaac E. Chief Executive Officer | 2018-07-09 | Sale | −27,859 | $39.88 | $1,111,017 | 128,219 | I: show line 1 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-07-09 | Sale | −2,141 | $40.63 | $86,989 | 126,078 | I: show line 2 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-07-10 | Sale | −22,300 | $39.93 | $890,439 | 103,778 | I: show line 3 in the form |
| Ciechanover Isaac E. Chief Executive Officer | 2018-07-10 | Sale | −6,100 | $40.54 | $247,294 | 97,678 | I: show line 4 in the form |
| Open-market sales · 58,400 sh · avg $40.00 · $2,335,739 | |||||||
Loading xslF345X03/doc4.xml…